CTNNB1 and liver cancer: We have shown that DAPK1 was significantly down-regulated in the CTNNB subtype of liver cancer, and importantly in liver cancer with a b-catenin mutation, the expression of DAPK1 mRNA was significantly lower compared to those liver cancer with wild-type b-catenin.